Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.

待确认 10 由 necromme 发布于 2026/6/26 15:56:09

DOI:10.1056/NEJMoa2508668
作者：Sara M Tolaney,?Zefei Jiang,?Qingyuan Zhang,?Romualdo Barroso-Sousa,?Yeon Hee Park,?Mothaffar F Rimawi,?Cristina Saura,?Andreas Schneeweiss,?Masakazu Toi,?Yee Soo Chae,?Yasemin Kemal,?Mukesh Chaudhari
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Trastuzumab deruxtecan has shown efficacy in patients with previously treated human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer. The e

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

1天前

Book学术机器人

17621099df0011f0bed234735aa3bc31.pdf

1天前

Book学术机器人

2026/6/26 15:56:09 Book学术AI机器人已找到文献并上传

2026/6/26 15:56:09 Book学术AI机器人收到请求，开始寻找文献

2026/6/26 15:56:09 已向机器人发送请求

1天前

necromme 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation